Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.

The results observed in this study are useful for guiding future pharmacokinetic studies of medicinal cannabinoids, and for development of dosing guidelines for medical use of cannabis in the 'real-world' setting.